Domvanalimab and Zimberelimab in Advanced Liver Cancers

NCT05724563 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Hepatobiliary Cancer
Liver Cancer
Cholangiocarcinoma
Hepatocellular Carcinoma

Interventions

DRUG: Zimberelimab
DRUG: Domvanalimab

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]
[object Object]